This company listing is no longer active
Resumen de acción RDSM
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Recompensas
Análisis de riesgos
Competidores de DSM-Firmenich AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €114.05 |
| 52 Week High | €157.25 |
| 52 Week Low | €108.30 |
| Beta | 0.72 |
| 1 Month Change | -4.32% |
| 3 Month Change | -8.17% |
| 1 Year Change | -21.59% |
| 3 Year Change | -2.23% |
| 5 Year Change | 28.72% |
| Change since IPO | 62.33% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| RDSM | AT Chemicals | Mercado AT | |
|---|---|---|---|
| 7D | 0% | 2.7% | 1.4% |
| 1Y | -21.6% | 1.7% | 5.1% |
Rentabilidad vs. Industria: RDSM underperformed the Austrian Chemicals industry which returned -7.2% over the past year.
Rentabilidad vs. Mercado: RDSM underperformed the Austrian Market which returned -8.5% over the past year.
Volatilidad de los precios
| RDSM volatility | |
|---|---|
| RDSM Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in AT Market | 5.0% |
| 10% least volatile stocks in AT Market | 1.7% |
Precio estable de las acciones: RDSM has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine RDSM's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
Resumen de fundamentos de DSM-Firmenich AG
| Estadísticas fundamentales de RDSM | |
|---|---|
| Capitalización bursátil | €762.73m |
| Beneficios(TTM) | €454.00m |
| Ingresos (TTM) | €8.39b |
1.7x
Ratio precio-beneficio (PE)0.1x
Ratio precio-ventas (PS)¿Está RDSM sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de RDSM | |
|---|---|
| Ingresos | €8.39b |
| Coste de los ingresos | €5.70b |
| Beneficio bruto | €2.69b |
| Otros gastos | €2.24b |
| Beneficios | €454.00m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
Aug 02, 2023
| Beneficios por acción (BPA) | 67.80 |
| Margen bruto | 32.06% |
| Margen de beneficio neto | 5.41% |
| Ratio deuda/patrimonio | 26.6% |
¿Cómo se ha desempeñado RDSM a largo plazo?
Ver rendimiento histórico y comparativa